ID   LB919-SCCHN
AC   CVCL_A8QP
DR   cancercelllines; CVCL_A8QP
DR   Wikidata; Q108820675
RX   PubMed=28765120;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ile655Val (c.1963A>G); ClinVar=VCV000013873; Zygosity=Unspecified (PubMed=28765120).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
RX   PubMed=28765120; DOI=10.1158/2326-6066.CIR-16-0400;
RA   Hennequart M., Pilotte L., Cane S., Hoffmann D., Stroobant V.,
RA   De Plaen E., van den Eynde B.J.;
RT   "Constitutive IDO1 expression in human tumors is driven by
RT   cyclooxygenase-2 and mediates intrinsic immune resistance.";
RL   Cancer Immunol. Res. 5:695-709(2017).
//